HMNC Brain Health Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
29
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$50M
- Investors
-
9
HMNC Brain Health General Information
Description
Provider of personalized therapies intended for depression and other neuropsychiatric disorders. The company combines the development of machine learning-enabled companion diagnostics with specific laboratory tests to personalize the treatment of neuropsychiatric complications with a focus on depression, stress, and sleep disorders, enabling patients to have the right medication and improve their quality of life.
Contact Information
Website
www.hmnc-brainhealth.comCorporate Office
- Wilhelm-Wagenfeld-Straße 20
- 80807 Munich
- Germany
Corporate Office
- Wilhelm-Wagenfeld-Straße 20
- 80807 Munich
- Germany
HMNC Brain Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B) | 15-Jun-2026 | $50M | Completed | Clinical Trials - Phase 2 | ||
| 3. Later Stage VC | 20-Oct-2022 | Completed | Clinical Trials - Phase 2 | |||
| 2. Later Stage VC (Series A) | 28-Jul-2021 | $23.7M | $33.1M | Completed | Clinical Trials - Phase 2 | |
| 1. Capitalization | $9.5M | $9.5M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
HMNC Brain Health Comparisons
Industry
Financing
Details
HMNC Brain Health Competitors (5)
One of HMNC Brain Health’s 5 competitors is AtaiBeckley, a Formerly VC-backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AtaiBeckley | Formerly VC-backed | New York, NY | ||||
| Denovo Biopharma | Venture Capital-Backed | Hangzhou, China | ||||
| COMPASS Pathways | Formerly VC-backed | Altrincham, United Kingdom | ||||
| GH Research | Formerly VC-backed | Dublin, Ireland | ||||
| Douglas (Pharmaceuticals and Biotechnology) | Corporation | Auckland, New Zealand |
HMNC Brain Health Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
HMNC Brain Health Patents
HMNC Brain Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024378457-A1 | Induction regime for the administration of 2-(2-chlorphenyl)-2-(methylamino) cyclohexan-1-one | Pending | 07-Nov-2023 | ||
| EP-4804999-A1 | Induction regime for the administration of 2-(2-chlorphenyl)-2-(methylamino) cyclohexan-1-one | Pending | 07-Nov-2023 | ||
| WO-2025099182-A1 | Induction regime for the administration of 2-(2-chlorphenyl)-2-(methylamino) cyclohexan-1-one | Inactive | 07-Nov-2023 | ||
| AU-2024378689-A1 | Maintenance regime for the administration of 2-(2-chlorphenyl)-2-(methylamino) cyclohexan-1-one | Pending | 07-Nov-2023 | ||
| EP-4804998-A1 | Maintenance regime for the administration of 2-(2-chlorphenyl)-2-(methylamino) cyclohexan-1-one | Pending | 07-Nov-2023 | A61K31/135 |
HMNC Brain Health Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
HMNC Brain Health Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Medice Arzneimittel Pütter | Corporation | Minority | ||
| MGV | Venture Capital | Minority | ||
| Carsten Maschmeyer Family Office | Family Office | Minority | ||
| GVB Family Office | Family Office | Minority | ||
| Angel (individual) | Minority |
HMNC Brain Health Investments (1)
HMNC Brain Health’s most recent deal was a Joint Venture with Ketabon. The deal was made on 01-Apr-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Ketabon | 01-Apr-2021 | Joint Venture | BPO/Outsource Services |
HMNC Brain Health FAQs
-
When was HMNC Brain Health founded?
HMNC Brain Health was founded in 2010.
-
Where is HMNC Brain Health headquartered?
HMNC Brain Health is headquartered in Munich, Germany.
-
What is the size of HMNC Brain Health?
HMNC Brain Health has 29 total employees.
-
What industry is HMNC Brain Health in?
HMNC Brain Health’s primary industry is Drug Discovery.
-
Is HMNC Brain Health a private or public company?
HMNC Brain Health is a Private company.
-
What is HMNC Brain Health’s current revenue?
The current revenue for HMNC Brain Health is .
-
How much funding has HMNC Brain Health raised over time?
HMNC Brain Health has raised $97.1M.
-
Who are HMNC Brain Health’s investors?
Medice Arzneimittel Pütter, MGV, Carsten Maschmeyer Family Office, GVB Family Office, and are 5 of 9 investors who have invested in HMNC Brain Health.
-
Who are HMNC Brain Health’s competitors?
AtaiBeckley, Denovo Biopharma, COMPASS Pathways, GH Research, and Douglas (Pharmaceuticals and Biotechnology) are competitors of HMNC Brain Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
